WEBSITECHANGES

Website Changes

---

06/20/2021

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

---

06/19/2021

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational brain cancer registry

---

06/17/2021

Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay

---

06/17/2021

Costly brain cancer drug no longer covered by Medicare

---

06/14/2021

Save the Date! Promo Discount Code for National Walk To End Brain Tumors: Clark, NJ 7/24/21

---

06/14/2021

Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma

---

06/11/2021

Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma

---

06/10/2021

Promising New Legislation Could Transform the FDA`s Drug Approval Process, Leading to Better Treatments and Lower Prices

---

06/09/2021

Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit

---

06/08/2021

Y-mAbs Announces Update on Omburtamab for DIPG

---

06/06/2021

Musella Foundation awards two more brain tumor research grants!

---

06/04/2021

Market Research Opportunity for Patients and Caregivers

---

06/04/2021

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

---

05/30/2021

Important Brain Tumor webinar tonight Sunday 5/30/21 7pm Eastern

---

05/25/2021

Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma

---

05/25/2021

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

---

05/25/2021

Japan to approve virotherapy drug for 1st time for cancer treatment

---

05/23/2021

Musella Foundation awards three brain tumor research grants!

---

05/23/2021

Brain Tumor Webinar Tonight (Sunday 5/23/21 at 7pm Eastern)

---

05/20/2021

A randomized phase II trial of veliparib, radiotherapy and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study

---

05/18/2021

Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Ra2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors

---

05/18/2021

The Promising Pathway Act was reintroduced in the Senate on May 13, 2021

---

05/18/2021

Navigated repetitive transcranial magnetic stimulation improves the outcome of postsurgical paresis in glioma patients – A randomized, double-blinded trial

---

05/18/2021

Webinar recordings posted to our brain tumor video library!

---

05/16/2021

Brain Tumor Webinar Tonight (Sunday 5/16/21 7pm Eastern)

---